Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $4.4 million.

  • MediWound's Cash from Investing Activities rose 13065.24% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 23137.73%. This contributed to the annual value of -$8.4 million for FY2024, which is 7553.39% up from last year.
  • As of Q3 2025, MediWound's Cash from Investing Activities stood at $4.4 million, which was up 13065.24% from $4.9 million recorded in Q2 2025.
  • MediWound's 5-year Cash from Investing Activities high stood at $5.0 million for Q4 2023, and its period low was -$26.1 million during Q2 2023.
  • Over the past 5 years, MediWound's median Cash from Investing Activities value was -$138000.0 (recorded in 2021), while the average stood at -$2.2 million.
  • In the last 5 years, MediWound's Cash from Investing Activities crashed by 869000.0% in 2022 and then surged by 13065.24% in 2025.
  • Over the past 5 years, MediWound's Cash from Investing Activities (Quarter) stood at -$116000.0 in 2021, then plummeted by 2173.28% to -$2.6 million in 2022, then surged by 290.67% to $5.0 million in 2023, then fell by 3.98% to $4.8 million in 2024, then dropped by 9.3% to $4.4 million in 2025.
  • Its Cash from Investing Activities was $4.4 million in Q3 2025, compared to $4.9 million in Q2 2025 and -$3.3 million in Q1 2025.